May 7, 2026 04:01PM
Nov 10, 2025 04:01PM
Oct 23, 2025 06:33AM
Oct 22, 2025 07:30AM
Oct 22, 2025 07:30AM
Aug 11, 2025 04:01PM
Jun 30, 2025 11:00AM Arcturus Therapeutics (ARCT) Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase Deficiency Program
Jun 30, 2025 11:00AM
Jun 23, 2025 08:30AM
May 12, 2025 04:01PM
Apr 11, 2025 06:37AM
Apr 10, 2025 08:00AM
Apr 10, 2025 08:00AM
Mar 10, 2025 06:44AM Arcturus Therapeutics (ARCT) PT Lowered to $60 at H.C. Wainwright
Mar 10, 2025 05:14AM
Mar 6, 2025 04:01PM
Feb 18, 2025 06:47AM
Feb 3, 2025 06:39AM
Jan 6, 2025 04:01PM
Nov 11, 2024 04:01PM
Nov 11, 2024 04:01PM Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
Nov 7, 2024 04:01PM
Oct 2, 2024 06:44AM
Sep 4, 2024 06:53AM
Sep 3, 2024 08:33AM
Sep 3, 2024 08:30AM
Jul 1, 2024 04:01PM
Jul 1, 2024 04:01PM Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs
Jun 7, 2024 10:32AM
Jun 7, 2024 10:30AM
May 28, 2024 06:30AM
May 28, 2024 06:30AM
Mar 7, 2024 04:01PM
Feb 22, 2024 08:31AM
Feb 22, 2024 08:30AM Arcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosis
Nov 27, 2023 08:31AM
Nov 27, 2023 08:30AM
Nov 14, 2023 04:01PM
Aug 7, 2023 04:01PM
Jun 1, 2023 08:30AM
Jun 1, 2023 08:30AM
May 12, 2023 08:45AM Devonian Health Group Announces the Appointment of New Board Members and Grant of Stock Options
Apr 21, 2022 06:14AM
Apr 20, 2022 07:31AM
Apr 20, 2022 07:30AM
Jan 18, 2022 07:00AM
Nov 8, 2021 04:00PM
Aug 10, 2021 09:25AM
Mar 1, 2021 04:01PM Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
Jan 4, 2021 07:02AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All